Chimpanzees drum with regular rhythm when they beat on tree trunks, a form of ancient communication
Chimpanzees and humans last shared a common ancestor around 6 million years ago. Scientists suspect this ancient ancestor must have been a drummer — using beats to communicate.
'Our ability to produce rhythm — and to use it in our social worlds — that seems to be something that predates humans being human,' said study co-author Cat Hobaiter, a University of St Andrews primatologist.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Thousands of cancer cases could be prevented with more breast removal surgeries
Thousands of breast cancer cases could potentially be prevented if more women were offered 'risk reducing' breast removal surgery, a study suggests. Breast removal surgery, also known as a mastectomy, is offered to treat breast cancer in some women. It can also be offered to women who are deemed to be high risk of the disease to prevent them from getting it in the first place. A study has found that if more women were given preventative mastectomies, then about 6,500 cases of breast cancer could be prevented each year. Risk-reducing mastectomies (RRM) are currently only offered to women with the BRCA1, BRCA2, PALB2 genes, experts said. But the new analysis suggests that some women with other genes linked to a higher risk of breast cancer – including ATM, CHEK2, RAD51C, RAD51D – who may also be at higher risk due to a number of other factors may benefit from RRM if they are assessed as having a high risk of disease. These other factors can include a family history of breast cancer, the number of children they have had, whether or not they breast fed and mammogram density. Women in the UK have an 11% chance of developing breast cancer across their lifetime. Medics can calculate a woman's risk of breast cancer using tools which combine the effect of various risk factors. This is your breast check reminder! Learn the signs and symptoms of breast — Breast Cancer Now (@BreastCancerNow) May 6, 2025 Researchers from Queen Mary University of London and the London School of Hygiene and Tropical Medicine (LSHTM) found that if health officials could identify all women aged 30 to 55 who have a 35% or higher risk of breast cancer, and they all went on to have RRM, then an estimated 6,538 breast cancer cases could be prevented in the UK each year. This is the equivalent of around 11% of the 59,000 women in the UK who are diagnosed with breast cancer each year. The academics point out that women who have one of the other genes linked to breast cancer, who may be at high risk of disease, could potentially be found by a mechanism called 'cascade testing' – where genetic tests are offered to family members of women who have been found to have these different genes linked to breast cancer. The economic evaluation study, published in the journal JAMA Oncology, concludes: 'Undergoing RRM appears cost-effective for women at 30-55 years with a lifetime BC-risk 35% (or more). 'The results could have significant clinical implications to expand access to RRM beyond BRCA1/BRCA2/PALB2 pathogenic variant carriers.' Corresponding author on the paper, Professor Ranjit Manchanda, professor of gynaecological oncology at Queen Mary and consultant gynaecological oncologist, said: 'We for the first time define the risk at which we should offer RRM. 'Our results could have significant clinical implications to expand access to mastectomy beyond those patients with known genetic susceptibility in high penetrance genes- BRCA1/ BRCA2/ PALB2 – who are traditionally offered this. 'This could potentially prevent can potentially prevent (around) 6500 breast cancer cases annually in UK women. 'We recommend that more research is carried out to evaluate the acceptability, uptake, and long-term outcomes of RRM among this group'. Dr Rosa Legood, associate professor in health economics at LSHTM, added: 'Undergoing RRM is cost-effective for women (aged) 30 to 55-years with a lifetime breast cancer risk of 35% or more. 'These results can support additional management options for personalised breast cancer risk prediction enabling more women at increased risk to access prevention.' Women deemed to be at high risk of breast cancer can also be offered regular screening and medication. Louise Grimsdell, Breast Cancer Now senior clinical nurse specialist, said: 'While this modelling provides valuable insights into the cost-effectiveness of risk-reducing mastectomy for women with a high risk of developing breast cancer, each individual must be offered all risk-management options that are suitable for them. 'Choosing to have risk-reducing surgery is a complex and deeply personal decision that comes with emotional and physical implications. 'So, it's vital women can consider all their options, including screening and risk-reducing medications, and are supported by their clinician to make an informed decision that's right for them. 'It's also crucial that the unacceptably long waits that far too many women who chose risk-reducing surgery are facing are urgently tackled.'
Bloomberg
3 hours ago
- Bloomberg
How the Mark Foundation Is Rebuilding the Cancer R&D Model
'I like the label 'new operating system.' I think that does capture well what we're trying to do here,' says Dr. Ryan Schoenfeld, CEO of the Mark Foundation. In this episode of Vanguards of Health Care, Schoenfeld joins Bloomberg Intelligence analyst Sam Fazeli to explore how the foundation is redesigning cancer research through global collaboration, platform thinking and a bold portfolio approach. They discuss the Foundation's growing international footpr int, why basic research is increasingly under threat in the US, and where new breakthroughs — including solid tumor CAR-T and glioblastoma — may emerge in the next five years.
Yahoo
5 hours ago
- Yahoo
Satellite tracker Spaceflux reaches lift-off with £5m funding boost
A British space surveillance company which has won a string of government contracts will this week announce a £5.4m fundraising to expand its global network of advanced telescopes. Sky News understands that Spaceflux, which was founded three years ago, has secured the injection of capital in a round led by the UK Innovation & Science Seed Fund (UKI2S), which is managed by Future Planet Capital, as well as Foresight Group and Blackfinch Ventures. Seraphim Space, the listed specialist investor in space-related companies, is also contributing funding. Money blog: Renowned chef thinks luxury item should be wiped off menus Spaceflux uses artificial intelligence and optical sensors to track satellites and debris across all orbits, with its daylight tracking capability meaning it can expand the observation window beyond night-time operations. Its provision of space situational awareness technologies is in growing demand amid warnings that a week-long disruption to satellite navigation could incur a £7.6bn hit to the UK economy. In a statement to Sky News, Marco Rocchetto, CEO and co-founder of Spaceflux, said: "As space becomes increasingly essential to our economy, environment and daily lives, it is also becoming more congested and contested. "This investment strengthens our ability to protect satellite technology that delivers crucial insights to Earth around the clock, reducing collision risks, and supporting a safer, more sustainable space environment for future generations". The valuation at which the funding was being committed was unclear on Thursday. Spaceflux, which serves government and commercial customers, has been the exclusive provider of geostationary satellite tracking for the Ministry of Defence and UK Space Agency since 2023. Read more on Sky News: Alex Leigh, an investment director at UKI2S, said: "This investment marks a significant step in the convergence of defence and space, where dual-use technologies are becoming increasingly important to UK capability. "Spaceflux's technology offers critical insights to help monitor and safeguard orbital assets - supporting both national security and the wider commercial ecosystem. "The company is well-positioned to scale its impact and meet the needs of customers navigating an increasingly complex space environment."
